# A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

> **NCT00047645** · PHASE3 · COMPLETED · sponsor: **InterMune** · enrollment: 330 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Interferon-gamma 1b

## Key facts

- **NCT ID:** NCT00047645
- **Lead sponsor:** InterMune
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2007-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047645, "A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00047645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*